Immunologic Biomarker Profile of Cerebrospinal Fluid

NCT04202055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2019-12-17

No results posted yet for this study

Summary

The aim of this study was the describe the Immunologic biomarker profile of cerebrospinal fluid in multiple sclerosis patients

Conditions

Interventions

OTHER

Biomarker analysis

Detection of biomarker in cerebrospinal fluid

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Eric Thouvenot · CHU Nimes

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04202055 on ClinicalTrials.gov